Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Laboratory Corp. of America Holdings    LH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Laboratory Corp. of America Holdings : LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2012 | 10:05pm CET

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 7, 2012, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $1.50 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is August 26, 2012. The payment of contingent cash interest is expected to be made on September 11, 2012.

About LabCorp®

Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $5.5 billion in 2011, over 31,000 employees worldwide, and more than 220,000 clients, LabCorp offers more than 4,000 tests ranging from routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its scientific expertise and innovative clinical testing technology through its specialized labs and the LabCorp Specialty Testing Group: The Center for Molecular Biology and Pathology, National Genetics Institute, ViroMed Laboratories, Inc., The Center for Esoteric Testing, Litholink Corporation, Integrated Genetics, Integrated Oncology, DIANON Systems, Inc., Monogram Biosciences, Inc., Colorado Coagulation, and Endocrine Sciences. LabCorp conducts clinical trials testing through its Esoterix Clinical Trials Services. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

This press release contains forward-looking statements. Each of the forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2011, and subsequent SEC filings.

LabCorp
Stephen Anderson, 336-436-5274
www.labcorp.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LABORATORY CORP. OF AMERIC
11/29 LABORATORY OF AMERICA : Research Reports Coverage on Healthcare Stocks -- Thermo..
11/23 LABORATORY OF AMERICA : Justification and Approval - Q-- VA258-16-AP-3767 Integr..
11/21 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
11/21 LABORATORY OF AMERICA : Computerworld Names Covance’s Dimitris Agrafiotis ..
11/20 LABORATORY OF AMERICA : More time = more money
11/02 LABORATORY OF AMERICA : Assigned Patent
11/01 LABORATORY CORPORATION OF AMERICA® H : LH) Files An 8-K
11/01 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
11/01 LABORATORY OF AMERICA : LabCorp is Scheduled to Present at the 2016 Credit Suiss..
10/28 LABORATORY OF AMERICA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
More news
Sector news : Healthcare Facilities & Services - NEC
09:10a CAMBIAN : UK health firm Cambian to sell adult services unit for 377 mln stg
11/24DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare 3Q Net Profit Up 46%
11/18 Synlab ready to snap up more lab chains after debt deal
11/16 South Africa's Life Healthcare to buy controlling stake in Britain's Alliance..
11/09 Pharma, biotech shares soar as Trump win calms pricing talk
More sector news : Healthcare Facilities & Services - NEC
News from SeekingAlpha
11/27 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q3 2016 Upda..
11/27 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2016 Updat..
11/25 Where Will CRISPR-Cas9 Work First?
11/18 Novartis and LabCorp among investors in developer of push button blood collec..
11/07 LAB CORP. : Pullback Play
Advertisement
Financials ($)
Sales 2016 9 405 M
EBIT 2016 1 503 M
Net income 2016 730 M
Debt 2016 5 286 M
Yield 2016 -
P/E ratio 2016 17,30
P/E ratio 2017 14,52
EV / Sales 2016 1,93x
EV / Sales 2017 1,76x
Capitalization 12 821 M
More Financials
Chart LABORATORY CORP. OF AMERIC
Duration : Period :
Laboratory Corp. of Americ Technical Analysis Chart | LH | US50540R4092 | 4-Traders
Full-screen chart
Technical analysis trends LABORATORY CORP. ...
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 147 $
Spread / Average Target 18%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David P. King Chairman, President & Chief Executive Officer
Glenn A. Eisenberg Chief Financial Officer, Treasurer & Executive VP
Mark Elliott Brecher Chief Medical Officer & Senior Vice President
Lance V. Berberian Chief Information Officer & Senior Vice President
Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LABORATORY CORP. OF AM..0.68%12 821
HCA HOLDINGS INC3.96%26 344
FRESENIUS MEDICAL CARE..-6.56%23 808
DAVITA INC-7.86%12 679
QUEST DIAGNOSTICS INC22.93%12 200
UNIVERSAL HEALTH SERVI..4.32%12 089
More Results